Eric W J Gates

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 11

Top Topics

Fluorescent Probe

High Efficiency

Top Venues

RSC medicinal chemistry

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Eric W J Gates, Adrien Prince-Hallée, Yasaman Heidari, Abootaleb Sedighi, Jeffrey W Keillor
High-Affinity Fluorogenic Substrate for Tissue Transglutaminase Reveals Enzymatic Hysteresis. Biochemistry (2023)
Eric W J Gates, Nicholas David Calvert, Nicholas J Cundy, Federica Brugnoli, Pauline Navals, Alexia Kirby, Nicoletta Bianchi, Gautam Adhikary, Adam J Shuhendler, Richard L Eckert, Jeffrey W Keillor
Cell-Impermeable Inhibitors Confirm That Intracellular Human Transglutaminase 2 Is Responsible for the Transglutaminase-Associated Cancer Phenotype. International journal of molecular sciences 24 (16) (2023)
Eric W J Gates, Kian Mansour, Sahar Ebrahimi Samani, Sammir Shad, Mari T Kaartinen, Jeffrey W Keillor
Peptidic Inhibitors and a Fluorescent Probe for the Selective Inhibition and Labelling of Factor XIIIa Transglutaminase. Molecules (Basel, Switzerland) 28 (4) (2023)
Eric W J Gates, Kian Mansour, Sahar Ebrahimi Samani, Sammir Shad, Mari T Kaartinen, Jeffrey W Keillor
Peptidic Inhibitors and a Fluorescent Probe for the Selective Inhibition and Labelling of Factor XIIIa Transglutaminase. Molecules (Basel, Switzerland) 28 (4) (2023)
Eric W J Gates, Kian Mansour, Sahar Ebrahimi Samani, Sammir Shad, Mari T Kaartinen, Jeffrey W Keillor
Peptidic Inhibitors and a Fluorescent Probe for the Selective Inhibition and Labelling of Factor XIIIa Transglutaminase. Molecules (Basel, Switzerland) 28 (4) (2023)
Nicholas J Cundy, Jane Arciszewski, Eric W J Gates, Sydney L Acton, Kyle D Passley, Ernest Awoonor-Williams, Elizabeth K Boyd, Nancy Xu, Élise Pierson, Catalina Fernandez-Ansieta, Marie R Albert, Nicole M R McNeil, Gautam Adhikary, Richard L Eckert, Jeffrey W Keillor
Novel irreversible peptidic inhibitors of transglutaminase 2. RSC medicinal chemistry 14 (2) (2022)
Rita Canella, Federica Brugnoli, Mariana Gallo, Jeffrey W Keillor, Anna Terrazzan, Elena Ferrari, Silvia Grassilli, Eric W J Gates, Stefano Volinia, Valeria Bertagnolo, Nicoletta Bianchi, Carlo M Bergamini
A Multidisciplinary Approach Establishes a Link between Transglutaminase 2 and the Kv10.1 Voltage-Dependent K + Channel in Breast Cancer. Cancers 15 (1) (2022)
Alana M M Rangaswamy, Pauline Navals, Eric W J Gates, Sammir Shad, Sarah K I Watt, Jeffrey W Keillor
Structure-activity relationships of hydrophobic alkyl acrylamides as tissue transglutaminase inhibitors. RSC medicinal chemistry 13 (4) (2022)
Rita Canella, Federica Brugnoli, Mariana Gallo, Jeffrey W Keillor, Anna Terrazzan, Elena Ferrari, Silvia Grassilli, Eric W J Gates, Stefano Volinia, Valeria Bertagnolo, Nicoletta Bianchi, Carlo M Bergamini
A Multidisciplinary Approach Establishes a Link between Transglutaminase 2 and the Kv10.1 Voltage-Dependent K + Channel in Breast Cancer. Cancers 15 (1) (2022)
Rita Canella, Federica Brugnoli, Mariana Gallo, Jeffrey W Keillor, Anna Terrazzan, Elena Ferrari, Silvia Grassilli, Eric W J Gates, Stefano Volinia, Valeria Bertagnolo, Nicoletta Bianchi, Carlo M Bergamini
A Multidisciplinary Approach Establishes a Link between Transglutaminase 2 and the Kv10.1 Voltage-Dependent K + Channel in Breast Cancer. Cancers 15 (1) (2022)
Nicholas J Cundy, Jane Arciszewski, Eric W J Gates, Sydney L Acton, Kyle D Passley, Ernest Awoonor-Williams, Elizabeth K Boyd, Nancy Xu, Élise Pierson, Catalina Fernandez-Ansieta, Marie R Albert, Nicole M R McNeil, Gautam Adhikary, Richard L Eckert, Jeffrey W Keillor
Novel irreversible peptidic inhibitors of transglutaminase 2. RSC medicinal chemistry 14 (2) (2022)